DCGO Stock Recent News

NEW YORK--(BUSINESS WIRE)--DocGo Inc. (Nasdaq: DCGO) (“DocGo” or the “Company”), a leading provider of technology-enabled mobile health services, announced today that the Company will release its financial results for the first quarter ended March 31, 2024 after the markets close on Wednesday, May 8, 2024. Management will also host a conference call to discuss these results at 5:00 p.m. ET on that day. Conference call and webcast details: Wednesday, May 8, 2024 5:00 p.m. ET 1-877-407-0784 (U.S.

DocGo, Inc. (DCGO) Q4 2023 Earnings Call Transcript

DocGo Inc. (DCGO) came out with quarterly earnings of $0.06 per share, missing the Zacks Consensus Estimate of $0.13 per share. This compares to earnings of $0.11 per share a year ago.

NEW YORK--(BUSINESS WIRE)--DocGo Inc. (Nasdaq: DCGO) (“DocGo” or the “Company”), a leading provider of technology-enabled mobile health services, announced today that the Company will release its financial results for the fourth quarter and full year ended December 31, 2023 after the markets close on Wednesday, February 28, 2024. Management will also host a conference call to discuss these results at 5:00 p.m. ET on that day. Conference call and webcast details: Wednesday, February 28, 2024 5:0.

NEW YORK--(BUSINESS WIRE)--DocGo Inc. (Nasdaq: DCGO), a leading provider of technology-enabled mobile health services, announced today that management will be participating in the following investor conferences in February and March: BTIG at Snowbird – The 11th Annual BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference February 13-14, 2024 – 1x1 investor meetings, contact your BTIG representative for additional information. TD Cowen 44th Annual Health Care Conference Ma.

Shares of DocGo (NASDAQ: DCGO ), a company known for its mobile medical services, are plunging lower following the publication of a short report by Fuzzy Panda. The short seller has accused the company of improper billing practices, a management team with connections to fraud and unethical practices and contract issues in regards to New York City migrant asylum seekers, among other allegations.

I believe DCGO remains undervalued and has strong growth prospects. Recent results show significant revenue growth and an increase in FY23 revenue guidance. Despite concerns about contract rejection, DCGO has a strong relationship with the New York City government and is well-positioned to address the issue.

NEW YORK--(BUSINESS WIRE)--DocGo, a leading provider of technology-enabled mobile health services (Nasdaq: DCGO), today announced that the company will be participating in the following investor conferences during the month of November. Needham & Company 4th Annual Tech Week November 15, 2023 – Virtual 1x1 investor meetings, contact your Needham representative for additional information. Canaccord Genuity MedTech Diagnostics and Digital Health & Services Forum November 16, 2023 – 1x1 in.

NEW YORK--(BUSINESS WIRE)--DocGo Inc. (Nasdaq: DCGO) (“DocGo” or the “Company”), a leading provider of technology-enabled mobile health services, today announced that the Company will release its financial results for the third quarter ended September 30, 2023 after the markets close on Monday, November 6, 2023. Management will also host a conference call to discuss these results at 5:00 p.m. EDT on that day. Conference call and webcast details: Monday, November 6, 2023 5:00 p.m. EDT 1-877-407-.

Its CEO resigned abruptly. His official bio stated falsely that he earned a master's degree in artificial intelligence (AI).